Skip to main content
SpringerLink
Log in

HIV Infection

  • Chapter
Diet and Human Immune Function

Part of the book series: Nutrition and Health ((NH))

  • 423 Accesses

Abstract

HIV has become a major threat to populations throughout the world. The number of fatalities from this pandemic surpasses those of any war in the history of humankind. During 2001, more than 5 million people worldwide were newly infected with the virus. It is estimated that during the next 10 yr, if there are no effective treatments, more than 20 million people will die from this epidemic (1). During the last 20 yr, HIV has been extensively studied, including the relationship between HIV infection and nutrition. Nutritional status affects the course of the infection from the onset, during latency, and its progression to AIDS, as well as throughout the course of opportunistic infections (2–19). Nutritional therapy is critical in settings where antiretroviral therapies are not available (19), as well as an adjunct to the combination antiretroviral drugs to support and maintain both the acquired and the innate nonspecific aspects of host defenses (20).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Joint United Nations Programme on HIV/AIDS. Report of HIV/AIDS Epidemic, 2002. A global overview of the epidemic. UNAIDS, Geneva, 2002, pp. 22–41.

    Google Scholar 

  2. Baum MK, Mantero-Atienza E, Shor-Posner G, et al. Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. J Acquir Immun Defic Syndr 1991;4:1122–1132.

    CAS  Google Scholar 

  3. Beach RS, Mantero-Atienza E, Shor-Posner G, et al. Specific nutrients abnormalities in asymptomatic HIV infection. AIDS 1992;6:701–708.

    Article  PubMed  CAS  Google Scholar 

  4. Baum MK. Nutritional alterations in high-risk groups in relationship to HIV-1 disease progression. Nutrition 1996;12:124–126.

    Article  PubMed  CAS  Google Scholar 

  5. Baum MK, Shor-Posner G, Lai S, et al. High risk of HIV-related mortality is associated with selenium deficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:370–374.

    Article  PubMed  CAS  Google Scholar 

  6. Baum MK, Shor-Posner G, Zhang G, et al. HIV-1 infection in women is associated with severe nutritional deficiencies. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:272–278.

    Article  PubMed  CAS  Google Scholar 

  7. Baum MK, Shor-Posner G. Micronutrient status in relationship to mortality in HIV-1 disease. Nutr Rev 1998;56(S1-S2):58–62.

    Google Scholar 

  8. Baum MK, Shor-Posner G, Campa A. Zinc status in human immunodeficiency virus infection. J Nutr 2000;130:1421S-1423S.

    Google Scholar 

  9. Baum K. Role of micronutrients in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr Hum Retrovirol 2000;25:S49-S52.

    Google Scholar 

  10. Shor-Posner G, Baum MK. Nutritional alterations in HIV-1 seropositive and seronegative drug users. Nutrition 1996;12:555–556.

    Article  PubMed  CAS  Google Scholar 

  11. Semba RD, Graham NMH, Waleska T, et al. Increased mortality associated with Vitamin A deficiency during Human Immunodeficiency Virus Type 1 infection. Arch Intern Med 1993;153:2149–2153.

    Article  PubMed  CAS  Google Scholar 

  12. Smit E, Graham NMH, Tang A, et al. Dietary intake of community based HIV-1 seropositive and seronegative injecting drug users. Nutrition 1996;12:496.

    Article  PubMed  CAS  Google Scholar 

  13. Semba RD, Caiaffa WT, Graham NMH, et al. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis 1995;171: 1196–1202.

    Article  PubMed  CAS  Google Scholar 

  14. Huang CM, Ruddel M, Ronald JE. Nutritional status of patients with acquired immunodeficiency syndrome. Clin Chem 1988;34:1957–1959.

    PubMed  CAS  Google Scholar 

  15. Tang AM, Graham NMH, Saah AJ. Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol 1996;143:1244–1256.

    Article  PubMed  CAS  Google Scholar 

  16. Tang AM, Graham NM, Chandra RK, Saah AJ. Low serum B12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J Nutr 1997;127:345–351.

    PubMed  CAS  Google Scholar 

  17. Constans J, Pellegrin JL, Sergeant C, et al. Serum selenium predicts outcome in HIV infection. J Acquir Immun Defic Syndr 1995;3:392.

    Google Scholar 

  18. Fawzi WW, Hunter DJ. Vitamins in HIV disease progression and vertical transmission. Epidemiology 1998;9:457–466.

    Article  PubMed  CAS  Google Scholar 

  19. Fawzi WW, Msamanga GI, Spiegelman D, et al. Randomized trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1 infected women in Tanzania. Lancet 1998;351: 1477–1482.

    Article  PubMed  CAS  Google Scholar 

  20. Beisel WR. AIDS. In: Gershwin ME, German JB, Keen CL (eds.). Nutrition and Immunology: Principles and Practices. Humana, Totowa, NJ, 2000, pp. 389–403.

    Google Scholar 

  21. Baum MK, Shor-Posner G, Lu Y, et al. Micronutients and HIV disease progression. AIDS 1995;9: 1051–1056.

    Article  PubMed  CAS  Google Scholar 

  22. Campa A, Shor-Posner G, Indacochea F, et al. Mortality risk in selenium deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol 1999;20:508–513.

    Article  PubMed  CAS  Google Scholar 

  23. Tang AM, Graham NM, Kirby AJ, McCall LD, Willet WC, Saah AJ. Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 1993;138:937–951.

    PubMed  CAS  Google Scholar 

  24. Tang AM, Graham NMH, Semba RD, et al. Association between serum viatmin A and E levels and HIV-1 disease progression. AIDS 1997;11:613–620.

    Article  PubMed  CAS  Google Scholar 

  25. Semba RD, Tang AM. Micronutrients and the pathogenesis of human immunodeficiency virus infection. Br J Nutr 1999;81:181–189.

    Article  PubMed  CAS  Google Scholar 

  26. Tang AM, Smith E. Selected vitamins in HIV infection: a review. AIDS Patient Care STD 1998;12: 263–273.

    Article  CAS  Google Scholar 

  27. Centers for Disease Control and Prevention. AIDS-Defining Criteria. Morbidity and Mortality Weekly Report, August 14, 1987 (Suppl 3S-15S).

    Google Scholar 

  28. Chlebowski RT, Grosvenor MB, Bernhard NH, et al. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol 1989;84:1288–1294.

    PubMed  CAS  Google Scholar 

  29. Kotler DP, Tierney AR, Wang J, et al. The magnitude of body cell mass depletion determines the timing to death from wasting in AIDS. Am J Clin Nutr 1989;50:444–447.

    PubMed  CAS  Google Scholar 

  30. Stuttmann U, Ockenga J, Selber O, et al. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr 1995;8: 239–246.

    Google Scholar 

  31. Hommes MJT, Romi FA, Endert E, Saierweomg JP. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic HIV: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr 1991;54:311–315.

    PubMed  CAS  Google Scholar 

  32. Pantaleo G, Graziosi C, Fauci AS. The immunopathogenesis of human immunodeficiency infection. N Engl J Med 1993;328:327–335.

    Article  PubMed  CAS  Google Scholar 

  33. American Gastroenterological Association. AGA Technical Review: Malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infections. Gastroenterology 1996;111:1724–1752.

    Article  Google Scholar 

  34. Lambi BB, Federman M, Pleskow D, Wanke CA. Malabsorption and wasting in AIDS patients with microsporidia and pathogen-negative diarrhea. AIDS 1996;10:739–744.

    Article  Google Scholar 

  35. Simply stated...are people still wasting? Res Initiat Treat Action 1998;4:15.

    Google Scholar 

  36. Roubenoff R, Grinspoon S, Skolnik PR, et al. Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol Endocrinol Metab 2002;283:E138-E145.

    Google Scholar 

  37. Kotler DP. Nutritional alterations associated with HIV infection. J Acquir Immune Defic Syndr 2000;25(Suppl 1):S81-S87.

    Google Scholar 

  38. Gilbert C, Launer C, Bartsch G, et al. Body weight and percent weight change as predictors of mortality in Abstract 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco, CA, September 1995.

    Google Scholar 

  39. Palenicek JP, Grahm NM, He YH, et al. Weight loss prior to clinical AIDS as a predictor of survival. J Acquir Immune Defic Syndr 1995;10:366–372.

    CAS  Google Scholar 

  40. Kotler DP. Body cell mass and survival in the AIDS patient. In: Herber D, Blackburn GL, Go VLW (eds.). Nutritional Oncology. Academic, London, 1999, pp. 547–560.

    Google Scholar 

  41. Kotler DP, Gaetz HP, Klein EB, et al. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:421–428.

    PubMed  CAS  Google Scholar 

  42. Kotler DP, Wang J, Pierson RN. Studies of body composition in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985;42:1255–1265.

    PubMed  CAS  Google Scholar 

  43. Kotler DP, Tierney AR, Dilmanian FA, et al. Correlation between total body potassium and total body nitrogen in patients with acquired immunodeficiency syndrome. Clin Res 1991;39:649A.

    Google Scholar 

  44. Gutierrez-Rodriguez R, Campa A, Shor-Posner G, Baum MK. Estado del metabolismo de los lipidos en la infeccion por VIH-1 y SIDA (Lipid metabolism status in HIV-1 infection and AIDS). Diagnostico 1998;37:336–343.

    Google Scholar 

  45. Grinspoon S, Corcoran C, Stanley T, Rabe J, Wilkie S. Mechanisms of androgen deficiency in human immunodeficiency virus-infected women with the wasting syndrome. J Clin Endocrinol Metab 2001;86:4120–4126.

    Article  PubMed  CAS  Google Scholar 

  46. Keithley JK, Swanson B, Zeller JM, et al. Comparison of standard and immune-enhancing oral formulas in asymptomatic HIV-infected persons: a multicenter randomized controlled clinical trial. JPEN J Parenter Enteral Nutr 2002;26:6–14.

    Article  PubMed  Google Scholar 

  47. Steinhart CR. HIV-associated wasting in the era of HAART: a practice-based approach to diagnosis and treatment. AIDS Read 2001;11:557–560,566–569.

    PubMed  CAS  Google Scholar 

  48. Solomon J, De TP, Melchior JC. Nutrition and HIV infection. Br J Nutr 2002;87(Suppl):S 111-S119.

    Article  CAS  Google Scholar 

  49. Baum, MK. Casetti, L. Bonvehi P. Inadequate intake and altered nutrition status in early HIV-1 infection. Nutrition 1994;10:16–20.

    PubMed  CAS  Google Scholar 

  50. Beach RS, Morgan R, Wilkie F, et al. Plasma vitamin B12 level as a potential cofactor in studies of human immunodeficiency virus type-1 related cognitive changes. Arch Neurol 1992;49:501–506.

    Article  PubMed  CAS  Google Scholar 

  51. Glade MJ. Nutrient supplementation in HIV/AIDS, Forum on Therapeutic Nutrition: 2000 Clinical Practice Update. Conference Summary 2000, Palisades, NY.

    Google Scholar 

  52. Robson LC, Schwartz RM. Perkins WD. The effects of vitamin B6 deficiency on the lymphoid system and immune responses. In: Tryfiates CP (ed.). Vitamin B6 Metabolism and Role in Growth. Food and Nutrition, Westport, CT, 1980, pp. 205–222.

    Google Scholar 

  53. Shor-Posner G, Feaster D, Blaney NT, Baum MK. Impact of vitamin B6 status on psychological distress in a longitudinal study of HIV infection. Intern J Psych Med 1994;24:209–222.

    Article  CAS  Google Scholar 

  54. Inubushi T, Okada M, Matsui A. Effect of dietary vitamin B6 contents on antibody production. Biofactors 2000;11:93–96.

    Article  PubMed  CAS  Google Scholar 

  55. Lee J, Yoshikawa K, Watson RR. Nutritional deficiencies in AIDS patients: a treatment opportunity. In: AIDS and Complementary and Alternative Medicine: Current Science and Practice (Standish LJ, Calabrese C, Galantino ML, eds.), Churchill Livingston, Bastyr Research, 2002, pp. 56–70.

    Chapter  Google Scholar 

  56. Harriman GR, Smith PD, Horne MK. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med 1989;149:2039–2041.

    Article  PubMed  CAS  Google Scholar 

  57. Partiel O, Falutz J, Veilleux M, Rosenblatt DS, Gordon K. Clinical correlates of subnormal vitamin B 12 levels in patients infected with the human immunodeficiency virus. Am J Hematol 1995;49:318–322.

    Article  Google Scholar 

  58. Kieburtz KD, Giang DW, Schiffer RB. Abnormal vitamin B 12 metabolism in human immunodeficiency virus infection: association with neurological dysfunction. Arch Neurol 1991;48:312–314.

    Article  PubMed  CAS  Google Scholar 

  59. Tamura J, Kubota K, Murakami H. Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12 deficient patient bymethyl-B 12 treatment. Clin Exp Immunol 1999;116:28–32.

    Article  PubMed  CAS  Google Scholar 

  60. Weinberg JB, Sauls DL, Misukonis MA, Shugars DC. “Inhibition of productive human immunodeficiency virus-1 infection by cobalamins.” Blood 1995;86:1281–1287.

    PubMed  CAS  Google Scholar 

  61. May BA. A novel antiviral strategy for HIV infection. Med Hypotheses 1993;40:93–94.

    Article  PubMed  CAS  Google Scholar 

  62. Herbert V, Fong W, Gulle V. Low holotranscobalamin II is the earliest serum marker for subnormal vitamin B12 absorption in patients with AIDS. Am J Hematol 1990;34:132–139.

    Article  PubMed  CAS  Google Scholar 

  63. Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenter or sole manifestation of human immuno-deficiency virus infection. Arch Neurol 1987;44;65–69.

    Article  PubMed  CAS  Google Scholar 

  64. Lindenbaum J, Savage DG, Stabler SP. Diagnosis of cobalamin deficiency: II relative sensitivities of serum cobalamin, methylmalonic acid and total homocysteine concentrations. Am J Hematol 1990;34:99–107.

    Article  PubMed  CAS  Google Scholar 

  65. Frenkel EP, Yardley DA. Clinical and laboratory features and sequelea of deficiency of folic acid (folate) and vitamin B12 (cobalamin) in pregnancy and gynecology. Hematol Oncol Clin N Am 2000;14:1079–1100.

    Article  CAS  Google Scholar 

  66. Ellison J. Intensive vitamin A therapy in meascles. BMJ 1932;2:708–711.

    Article  PubMed  CAS  Google Scholar 

  67. West CE. Vitamin A and measles. Nutr Rev 2000;58:S46-S54.

    Article  Google Scholar 

  68. Sempertegui F, Estrella B, Camaniero V, et al. The beneficial effects of weekly low-dose vitamin A supplementation on acute lower respiratory infections and diarrhea in Ecuatorian children. Pediatrics 1999;104:41.

    Google Scholar 

  69. Sommer A, Tarwotjo I, Hussaini G, Susanto D. Increased mortality in children with mild vitamin A deficiency. Lancet 1983;2:585–588.

    Article  PubMed  CAS  Google Scholar 

  70. Sommer A, Tarwotjo I, Djunaedi E, et al. Impact of vitamin A supplementation on childhood mortality: a randomized controlled community trial. Lancet 1986;1:1169–1173.

    Article  PubMed  CAS  Google Scholar 

  71. Bloem MW, Wedel M, Egger RJ, et al. Mild vitamin A deficiency and risk of respiratory tract diseases and diarrhea in preschool and school children in Northeast Thailand. Am J Epidemiol 1990; 131:332–339.

    PubMed  CAS  Google Scholar 

  72. Shankar AH, Genton B, Semba RD, et al. Effect of vitamin A supplementation on morbidity due to Plasmodium falciparum in young children in Papua New Guinea: a randomised trial. Lancet 1999;354:203–209.

    Article  PubMed  CAS  Google Scholar 

  73. Fawzi WW, Chalmers T, Herrera M, Mosteller F. Vitamin A supplementation and child mortality: a meta-analysis. JAMA 1993;269:898–903.

    Article  PubMed  CAS  Google Scholar 

  74. D’Souza RM, D’Souza R. Vitamin A for preventing secondary infections in children with measlesa systematic review. J Trop Pediatr 2002;48:72–77.

    Article  PubMed  Google Scholar 

  75. Villamor E, Fawzi WW. Vitamin A supplementation: implications for morbidity and mortality in children. J Infect Dis 2000;182(Suppl 1):S122-S133.

    Article  Google Scholar 

  76. Whitney EN, Rolfes SR. The fat-soluble vitamins: A, D, E, and K. In: Understanding Nutrition (9th ed.). Wadsworth/Thomson Learning, Belmont, CA, 2002, pp. 354–385.

    Google Scholar 

  77. Semba RD. Vitamin A and immunity to viral, bacterial and protozoan infections. Proc Nutr Soc 1999;58:719–727.

    Article  PubMed  CAS  Google Scholar 

  78. Semba RD., Vitamin A, immunity and infection. Clin Infect Dis 1994;19:489–499.

    Article  PubMed  CAS  Google Scholar 

  79. Ross AC, Stephensen CB. Vitamin A and retinoids in antiviral responses. FASEB J 1996;10:979–985.

    PubMed  CAS  Google Scholar 

  80. Watson R, Prabhala R, Plezia P, Alberts D. Effect of B-carotene on lymphocyte subpopulations in elderly humans: a dose-response relationship. Am J Clin Nutr 1991;53:90–94.

    PubMed  CAS  Google Scholar 

  81. Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1995;343:1593–1597.

    Article  Google Scholar 

  82. Periquet BA, Jammes NM, Lambert WE, et al. Micronutrient levels in HIV-1-infected children. AIDS 1995;96:696–702.

    Google Scholar 

  83. Camp WL, Allen S, Alvarez JO, et al. Serum retinol and HIV-1 RNA viral load in rapid and slow progressors. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:21–26.

    Article  PubMed  CAS  Google Scholar 

  84. Rich KC, Fowler MG, Mofenson LM, et al. Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group. Pediatrics 2000;105:E8.

    Google Scholar 

  85. Burger H, Kovacs A, Weiser B, et al. Maternal serum vitamin A levels are not associated with motherto-child transmission of HIV-1 in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:321–326.

    Article  PubMed  CAS  Google Scholar 

  86. Semba RD. Overview of the potential role of vitamin A in mother-to-child transmission of HIV-1. Acta Paediatr Suppl 1997;421:107–112.

    Article  PubMed  CAS  Google Scholar 

  87. Fawzi W. Nutritional factors and vertical transmission of HIV-1. Epidemiology and potential mechanisms. Ann N Y Acad Sci 2000;918:99–114.

    Article  PubMed  CAS  Google Scholar 

  88. Fawzi WW, Msamanga GI, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS 2002;16:1935–1944.

    Article  PubMed  CAS  Google Scholar 

  89. Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to vertical transmission in HIV-1 in Tanzania. J Acquir Immune Defic Syndr 2000;23:246–254.

    PubMed  CAS  Google Scholar 

  90. Coutsudis A, Pillay K, Spooner E, et al. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS 1999;13:1517–1524.

    Article  Google Scholar 

  91. Kumwenda N, Miotti PG, Taha TE, et al. Antenatal vitamin A supplementation increases birth weight and decreases anemia among infants born to human immunodeficiency virus-infected women in Malawi. Clin Infect Dis 2002;35:618–624.

    Article  PubMed  CAS  Google Scholar 

  92. French AL, Cohen MH, Gange SJ, et al. Vitamin A deficiency and genital viral burden in women infected with HIV-1. Lancet 2002;359:1210–1212.

    Article  PubMed  CAS  Google Scholar 

  93. Shey WI, Brocklehurst P, Sterne JA.Vitamin A supplementation for reducing the risk of mother-tochild transmission of HIV infection. Cochrane Database Syst Rev 2002:CD003648.

    Google Scholar 

  94. Villamor E, Mbise R, Spiegelman D, et al. Vitamin A supplements ameliorate the adverse effect of HIV1, malaria, and diarrheal infections on child growth. Pediatrics 2002;109:E6.

    Article  Google Scholar 

  95. Fawzi WW, Mbise RL, Hertzmark E, et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Ped Infect Dis J 1999;18:127–133.

    Article  CAS  Google Scholar 

  96. Coutsoudis A, Bobat RA, Coovadia HM, Kuhn L, Tsai WY, Stein ZA. The effects of vitamin A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health 1995;85:1076–1081.

    Article  PubMed  CAS  Google Scholar 

  97. Meydani SN, Barklund MP, Liu S, et al. Vitamin E supplementation enhances cell-mediated immunity in healthy subjects. Am J Clin Nutr 1991;53:976–977.

    Google Scholar 

  98. Tengerdy RP. The role of vitamin E in immune response and disease resistance. Ann N Y Acad Sci 1990;587:24–33.

    PubMed  CAS  Google Scholar 

  99. Odeleye OE, Watson RR. The potencial role of immunologic abnormities during acquired immune deficiency syndrome. Prog Food Nutr Sci 1991:15:1–19.

    PubMed  CAS  Google Scholar 

  100. Pontes Monteiro J, Ferreira da Cunha D, Freire Carvaho Cunha S. Nutrition assessment of vitamin E in malnourished patients with AIDS. Nutrition 2000;16:339–343.

    Article  PubMed  CAS  Google Scholar 

  101. Wang Y, Huang DS, Liang B, Watson RR. Nutritional status and immune responses in mice with murine AIDS are normalized by vitamin E supplementation. J Nutr 1994;124:2024–2032.

    CAS  Google Scholar 

  102. Han SN, Wu D, Ha WK, et al. Vitamin E supplementation increases T helper 1 cytokine production in old mice infected with influenza virus. Immunology 2000;100:487–493.

    Article  PubMed  CAS  Google Scholar 

  103. Beharka AA, Wu D, Han SN, Meydani SN. Macrophage prostaglandin production contributes to the age-associated decrease in T cell function which is reverse by the dietary antioxidant vitamin E. Mech Ageing Dev 1997;93:59–77.

    Article  CAS  Google Scholar 

  104. Malvy DJM, Richard MJ, Arnaud J, Favier A, Amedee-Manesme O. Relationship of plasma malondiadehyde, vitamin E and antioxidant micronutrients to human immunodeficiency virus-1 seropositive. Clin Chim Acta 1994;224:89–94.

    Article  PubMed  CAS  Google Scholar 

  105. Constans J, Peuchant E, Pellegrin JL, et al. Fatty acids and plasma antioxidants in HIV-positive patients: correlation with nutritional and immunological status. Clin Biochem 1995;28:421–426.

    Article  PubMed  CAS  Google Scholar 

  106. Shor-Posner G, Miguez-Burbano MJ, Lu Y, et al. Elevated IgE level in relationship to nutritional status and immune parameters in early human immunodeficiency virus-1 disease. J Allergy Clin Immunol 1995;95:886–892.

    Article  PubMed  CAS  Google Scholar 

  107. Beisel WR. Nutrition and Infection. In: Linder MC (ed.) Nutritional Biochemistry and Metabolism (2nd ed.). Elsevier, New York, 1995, pp. 507–542.

    Google Scholar 

  108. Moyle G. Anaemia in persons with HIV infection: prognostic marker and contributor to morbidity. AIDS Rev 2002;4:13–20.

    PubMed  Google Scholar 

  109. Semba RD, Gray GE. Pathogenesis of anemia during human immunodeficiency virus infection. J Investig Med 2001;49:225–239.

    Article  PubMed  CAS  Google Scholar 

  110. Gupta S, Imam A, Licorish K. Serum ferritin in acquired immune deficiency syndrome. J Clin Lab Immunol 1986;20:11–13.

    PubMed  CAS  Google Scholar 

  111. De Monye C, Karcher DS, Boelaert JR, Gordeuk VR. Bone marrow macrophage iron grade and survival of HIV-seropositive patients. AIDS 1999;25:375–380.

    Article  Google Scholar 

  112. Weiss G, Wachter H. Linkage of cellular immunity to iron metabolism. Immunol Today 1995;16: 495–500.

    Article  PubMed  CAS  Google Scholar 

  113. Semba RD, Taha TE. Iron status and indicators of human immuno-deficiency virus disease severity among pregnant women in Malawi. Clin Infect Dis 2001;32:1496–1499.

    Article  PubMed  CAS  Google Scholar 

  114. Castaldo A, Tarallo L, Palomba E, et al. Iron deficiency and intestinal malabsorption in HIV disease. J Pediat Gastroenterol Nutr 1996;22:359–363.

    Article  CAS  Google Scholar 

  115. Savarino A, Pescarmona GP, Boelaert JR. Iron metabolism and HIV infection: reciprocal interactions with potentially harmful consequences? Cell Biochem Funct 1999;17:279–287.

    Article  PubMed  CAS  Google Scholar 

  116. Sappey C, Boelaert JR. Iron chelation decreases NF-kappa B and HIV type-1 activation due to oxidative stress. AIDS Res Human Retrovir 1995;11:1049–1061.

    Article  CAS  Google Scholar 

  117. Delanghe J, Langlosis M. Haptoglobin polymorphism, iron metabolism and mortality in HIV infection. AIDS 1998;12:1027–1032.

    Article  PubMed  CAS  Google Scholar 

  118. Afacan YE, Hasan MS, Jackson AO. Iron deficiency anemia in HIV infection: immunologic and virologic response. J Nat Med Assoc 2002;94:73–77.

    Google Scholar 

  119. Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ, van Asbeck BS. Inhibition of human immunodeficient virus type 1 replication in human mononuclear blood cells by iron chelators deferoxamine, deferiprone and bleomycin. J Infect Dis 2000;181:484–490.

    Article  PubMed  CAS  Google Scholar 

  120. Costagliola DG, de Montalembert M, Lefrere JJ, et al. Dose of deferrioxamine and evolution of HIV infection in thalassaemic patients. Br J Haematol 1994;87:849–852.

    Article  PubMed  CAS  Google Scholar 

  121. Jacobus DP. Randomization to iron supplementation of patients with advanced human immunodeficiency virus diseasean inadvertent but controlled study with results important for patient care. J Infect Dis 1996;153:1044–1045.

    Article  Google Scholar 

  122. Clark TD, Semba RD. Iron supplementation during human immunodeficiency virus infection: a doubleedge sword? Med Hypotheses 2001;57:476–479.

    Article  PubMed  CAS  Google Scholar 

  123. Bologna R, Indacochea F, Shor-Posner G, et al. Selenium and immunity in HIV-1 infected pediatric patients. J Nutr Immunol 1994;2:41–49.

    Article  Google Scholar 

  124. Baeten JM, Mostad SB, Hughes MP, et al. Selenium deficiency is associated with shedding of HIV-1infected cells in the female genital tract. J Acquir Immune Defic Syndr 2001;26:360–364.

    PubMed  CAS  Google Scholar 

  125. Miguez-Burbano MJ, Campa A, Shor-Posner G, et al. Incidence of herpes infection in HIV-1 infected chronic drug users in relationship to selenium status. STI and The Millenium, a Joint Meeting of the ASTDA and the MSSVD, Baltimore, MD, May 3–6, 2000.

    Google Scholar 

  126. Shor-Posner G, Miguez MJ, Pineda LM, et al. Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol 2002;29:169–173.

    CAS  Google Scholar 

  127. Taylor EW, Ramanathan CS, Nadimpalli RG, et al. Do some viruses encode selenoproteins? Assessment of the theory in the light of current theoretical, experimental and clinical data. Antiviral Res 1995;26:A271-A286.

    Google Scholar 

  128. Taylor EW, Ramanathan CS, Nadimpally RG. A general method for predicting new genes in nucleic acid sequences: application to the human immunodeficiency virus. In: Witten M (ed.). Computational Medicine, Public Health, and Biotechnology. Vol. 1. World Scientific, Singapore, 1996, pp. 285–309.

    Google Scholar 

  129. Taylor EW, Ramanathan CS. Theoretical evidence that the Ebola virus Zaire strain may be seleniumdependent: a factor in pathogenesis and viral outbreaks? J Orthomol Med 1996;10:131–138.

    Google Scholar 

  130. Taylor EW, Nadimpalli RG, Ramanathan CS. Genomic structure of viral agents in relation to the biosynthesis of seleno proteins. In: Scharauzer GN, Montagnier L (eds.). Proceedings of the first international symposium on “Human viral diseases: selenium, antioxidants and other emerging strategies of therapy and prevention,” April 1996, Nonwiler, Germany. Biol Trace Elem Res 1997;56: 63–91.

    Google Scholar 

  131. Dworkin BM, Rosenthal WS, Wormser GP, et al. Abnormalities of blood selenium and glutathione peroxidase in patients with acquired immunodeficiency syndrome and AIDS-related complex. Biol Trace Elem Res 1988;20:86–96.

    Google Scholar 

  132. Scrimshaw NS, SanGiovanni JP. Synergism of nutrition, infecion, and immunity: an overview. Am J Clin Nutr 1997;66:464S-477S.

    Google Scholar 

  133. Look MP, Rocstroh JK, Rao GS, Kreuzer KA, Spengler U, Sauerbruch T. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res 1997;56:31.

    Article  PubMed  CAS  Google Scholar 

  134. Spallholz JE. Anti-inflammatory, immunologic and carcinostatic attributes of selenium in experimental animals. Adv Exp Med Biol 1981;135:43–62.

    PubMed  CAS  Google Scholar 

  135. Roy M, Kiremidjian-Schumacher L, Wishe HI, Cohen MW, Stotzky G. Selenium supplementation enhances the expression of interleukin 2 receptor subunits and internalization of interleukin 2. Proc Soc Exp Biol Med 1993;202:295–231.

    PubMed  CAS  Google Scholar 

  136. Haslett PA. Anticytokine approaches to the treatment of anorexia and cachexia. Sem Oncol 1998;25: 53–57.

    CAS  Google Scholar 

  137. Hori K, Hatfield D, Maldarelli F, Lee BJ, Close KA. Selenium supplementation suppresses tumor necrosis factor alpha-induced human immunodeficiency virus replication in vitro. AIDS Res Hum Retrovir 1997;13:1325–1332.

    Article  PubMed  CAS  Google Scholar 

  138. Moutet M, d’Alessio P, Mlette P, Dvaux V, Chaudiere J. Glutathione peroxidase mimics prevent TNF and neutrophil induced endothelial alterations. Free Radic Biol Med 1998;25:270–281.

    Article  PubMed  CAS  Google Scholar 

  139. Sappey C, Legrand-Poels S, Best-Belpomme M, Favier A, Rentier B, Piette J. Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress. AIDS Res Human Retrovir 1994;10:1451–1461.

    Article  CAS  Google Scholar 

  140. Clark LC, Combs GF, Turnbull BW, et al. The nutritional prevention of cancer with selenium 1983–1993: a randomized clinical trial. JAMA 1996;276:1957–1963.

    Article  PubMed  CAS  Google Scholar 

  141. Yu SY, Zhu YJ, Li WG, et al. A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China. Biol Trace Elem Res 1991;29:289–294.

    Article  PubMed  CAS  Google Scholar 

  142. Yu SY, Chu YJ, Li WG. Selenium chemoprevention of liver cancer in animals and possible human applications. Biol Trace Elem Res 1998;15:231–241.

    Article  Google Scholar 

  143. Clark LC, Combs GS, Turnbull BW. The nutritional prevention of cancer with selenium 1983–1993: a randomized trial. FASEB J 1996;10:550.

    Google Scholar 

  144. Li JY, Taylor PR, Li B, et al. Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysphasia. J Natl Cancer Inst 1993;85:1492–1498.

    Article  PubMed  CAS  Google Scholar 

  145. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483–1492.

    Article  PubMed  CAS  Google Scholar 

  146. Delmas-Beauvieux MC, Peuchant E, Coucouron A, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or B-carotene. Am J Clin Nutr 1996;64:101–107.

    PubMed  CAS  Google Scholar 

  147. Spallholz JE, Boylan LM, Larsen HS. Advances in understanding selenium’s role in the immune system. Ann N Y Acad Sci 1990;587:123–139.

    PubMed  CAS  Google Scholar 

  148. Peretz A, Neve J, Desmedt J, Duchateau J, Dramaix M, Famaey J-P. Lymphocyte response is enriched by supplementation of elderly subjects with selenium-enriched yeast. Am J Clin Nutr 1991;53:1323–1328.

    PubMed  CAS  Google Scholar 

  149. Bonomini M, Forster S, De Risio F, et al. Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis. Nephrol Dial Transplant 1995;10:1654–1661.

    PubMed  CAS  Google Scholar 

  150. Harvima RJ, Jegerroos H, Kajander EO, et al. Screening of effects of selenomethionine-enriched yeast supplementation on various immunological and chemical parameters of skin and blood in psoriatic patients. Acta Derm Venereol 1993;73:88–91.

    PubMed  CAS  Google Scholar 

  151. Peretz A, Neve J, Duchateau J, et al. Effects of selenium supplementation on immune parameters in gut failure patients on home parenteral nutrition. Nutrition 1991;7:215–221.

    PubMed  CAS  Google Scholar 

  152. Cirelli A, Ciardi M, De Simone C, et al. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem 1991;24:211–214.

    Article  PubMed  CAS  Google Scholar 

  153. Olmsted L, Schrauzer GN, Flores-Arce M, Dowd J. Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res 1989;20:59–65.

    Article  PubMed  CAS  Google Scholar 

  154. Schrauzer GN, Sacher J. Selenium in the maintenance and therapy of HIV-infected patients. Chem Biol Interact 1994;91:199–205.

    Article  PubMed  CAS  Google Scholar 

  155. Kavanaugh-McHugh AL, Ruff A, Perlman E, Hutton N, Modlin J, Rowe S. Selenium deficiency and cardiomyopathy in acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 1991;15:347–349.

    Article  PubMed  CAS  Google Scholar 

  156. Alfthan G, Xu GL, Tan WH, et al. Selenium supplementation of children in a selenium-deficient area in China: blood selenium levels and glutathione peroxidase activities. Biol Trace Elem Res 2000;73:113–125.

    Article  PubMed  CAS  Google Scholar 

  157. Miguez-Burbano MJ, Shor-Posner G, Perez E, et al. Selenium and glucose homeostasis in the HAART era. XIII International HIV/AIDS Conference, Durban, South Africa, July 9–14, 2000. Abstract 8704.

    Google Scholar 

  158. Miguez-Burbano MJ, Burbano X, Campa A, et al. Selenium and platelet in the HAART era. Abstract accepted at FASEB 2001, March 31-April 4, Orlando, FL.

    Google Scholar 

  159. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-F58.

    Article  Google Scholar 

  160. Halliwell B. Oxidation of low-density lipoproteins: questions of initiation, propagation, and the effect of antioxidants. Am J Clin Nutr 1995;61:670S-677S.

    Google Scholar 

  161. Endre L, Beck F, Prasad A. The role of zinc in human health. J Trace Elem Exp Med 1990;3:337–375.

    CAS  Google Scholar 

  162. Fraker PJ, King L, Garvy B, Medina C. Immunopathology of zinc deficiency: a role for apoptosis. In: Klurfeld D (ed.). Human Nutrition—A Comprehensive Treatise (vol. 8). Plenum, New York, 1993, pp. 267–283.

    Google Scholar 

  163. Keen CL, Gershwin ME. Zinc deficiency and immune function. Ann Rev Nutr 1990;10:415–431.

    Article  CAS  Google Scholar 

  164. Fraker PH, Haas SM, Luecke RW. Effect of zinc deficiency on the immune response of the young adult A/J mouse. J Nutr 1977;107:1889–1895.

    PubMed  CAS  Google Scholar 

  165. Fernandes G, Nair M, Onoe K, Tanaka T, Floyd R, Good R. Impairment of cell mediated immunity function by dietary zinc deficiency in mice. Proc Natl Acad Sci USA 1979;76:457–461.

    Article  PubMed  CAS  Google Scholar 

  166. Wirth JJ, Fraker PJ, Kierszenbaum F. Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. Immunology 1989;68:114–114.

    PubMed  CAS  Google Scholar 

  167. Odeh M. The role of zinc in acquired immunodeficiency syndrome. J Int Med 1992;231:463–469.

    Article  CAS  Google Scholar 

  168. Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr 1997;66:460S-463S.

    Google Scholar 

  169. Fabris N, Mocchegiani E. Zinc, human diseases and aging. Aging (Milano) 1995;7:77–93.

    CAS  Google Scholar 

  170. Champion S, Imhof BS, Savagner P, et al. The embryonic thymus produces chemotactic peptides involved in the homing of hemopoietic precursors. Cell 1986;44:781–790.

    Article  PubMed  CAS  Google Scholar 

  171. Chandra RK. Trace element regulation of immunity and infection. J Am Coll Nutr 1985;4:5–16.

    PubMed  CAS  Google Scholar 

  172. Fraker P. Impact of nutritional status on immune integrity. In: Gershwin ME, German JB, Keen CL (eds.). Nutrition and Immunology. Humana, Totowa, NJ, 2000, pp. 147–156.

    Google Scholar 

  173. Prasad AS. Effect of zinc deficiency on Th 1 and Th2 cytokines shift. J Infect Dis 2000;182(Suppl 1):S62-S68.

    Article  Google Scholar 

  174. Dowd PS, Kelleher J, Guillou PJ. T-lymphocyte subsets and interleukin-2 production in zinc deficient rats. Br J Nutr 1986;55:59–65.

    Article  PubMed  CAS  Google Scholar 

  175. Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med 1987;316:479–485.

    Google Scholar 

  176. Flieger D, Riethmuller G, Ziegler-Heitbrock HWL. Zn2+ inhibits both tumor necrosis factor-mediated DNA fragmentation and cytolysis. Int J Cancer 1989;44:315–319.

    Article  PubMed  CAS  Google Scholar 

  177. Rosenberg ZF and Fauci AS. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990;11:176–180.

    Article  PubMed  CAS  Google Scholar 

  178. King JC, Keen CL. Zinc. In: Shils ME, Olson JA, Shike M, Ross AC (eds.). Modern Nutrition in Health and Disease (9th ed.). Lea and Febinger, Philadelphia, 1999, pp. 223–240.

    Google Scholar 

  179. Falutz J, Tsoukas C, Gold P. Zinc as a cofactor in human immunodeficiency virus-induced immunosuppression. JAMA 1988;259:2850–2851.

    Article  PubMed  CAS  Google Scholar 

  180. Graham NMH, Sorenson D, Odaka N, et al. Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr 1991;4:976–980.

    PubMed  CAS  Google Scholar 

  181. Lai H, Lai S, Shor-Posner G, et al. Plasma zinc, copper, copper/zinc ratio and survival in a cohort of HIV-1 infected homosexual men. J AIDS 2001;27:56–62.

    CAS  Google Scholar 

  182. Campa A, Baum K, Lai S, et al. Significant association between poor dietary zinc intake and zinc deficiency in HIV infected drug users. XIV International AIDS Conference, Barcelona, July 7–12, 2002, Abstract B10517.

    Google Scholar 

  183. Baum MK, Campa A, Lai S, et al. Zinc intake and mortality in HIV-1 infected drug users. XIV International AIDS Conference, Barcelona, July 7–12, 2002, Abstract and Poster ThPeB7323: 415.

    Google Scholar 

  184. Edeas MA, Peltier E, Claise C, et al. Immunocytochemical study of uptake of exogenous carrier-free copper-zinc superoxidase dismutase by peripheral blood lymphocytes. Cell Mol Biol 1996;42:1137–1143.

    PubMed  CAS  Google Scholar 

  185. Sprietsma JE. Zinc-controlled Thl/Th2 switch significantly determines development of diseases. Med Hypotheses 1997;49:1–14.

    Article  PubMed  CAS  Google Scholar 

  186. Lee PS, Xiao J, Knutson JR, et al. Zn2+ promotes the self-association of human immunodeficiency virus type-1 integrase in vitro. Biochemistry 1997;36:173–180.

    Article  PubMed  CAS  Google Scholar 

  187. Berthoux L, Pechoux C, Ottman M, et al. Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis. J Virol 1997;71:6973–6981.

    PubMed  CAS  Google Scholar 

  188. Darlix JL, Lapadat-Tapolsky M, de Rocquigny H, et al. First glimpses at structure-function relationships of the nuclecapsid protein of retroviruses. J Mol Biol 1995;254:523–537.

    Article  PubMed  CAS  Google Scholar 

  189. Zheng R, Jenkins TM, Craigie R. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity. Proc Natl Acad Sci USA 1996;93:13659–13664.

    Article  PubMed  CAS  Google Scholar 

  190. Huang HW, Wang KT. Structural characterization of the metal binding site in the cysteine-rich region of HIV-1 Tat protein. Biochem Biophys Res Commun 1996;227:615–621.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Marianna K. Baum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adriana Campa
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Nutrition Division, Institute of Food Research, Norwich Research Park, Norfolk, UK

    David A. Hughes PhD, RNutr

  2. Epsom and St. Helier University Hospitals NHS Trust, Surrey, UK

    L. Gail Darlington MD, FRCP

  3. GlaxoSmithKline Consumer Healthcare, Parsippany, NJ, USA

    Adrianne Bendich PhD, FACN

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Baum, M.K., Campa, A. (2004). HIV Infection. In: Hughes, D.A., Darlington, L.G., Bendich, A. (eds) Diet and Human Immune Function. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-652-2_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-652-2_16

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-422-7

  • Online ISBN: 978-1-59259-652-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation